AbramsS.M.FieldT.ScafidiF.ProdrodmidisM.1994Maternal “depression: Effects on infants' Brazelton Scale performance. Infant Mental Health Journal15:368–375.
2.
BearerC.LeeS.YamashitaT.SalvatorA.SingerL.T. In press Fatty acid ethyl esters: A biomarker for prenatal alcohol exposure. Alcoholism: Clinical and Experimental Research in press.
3.
BreslauN.KilbeyM.AndreskiP.1993Nicotine dependence and major depression. Archives of General Psychiatry50:31–35.
4.
BrookJ.S.CohenP.BrookD.W.1998Longitudinal and co-occurring psychiatric disorders and substance us. Journal of the American Academy of Child and Adolescent Psychiatry37:332–330.
5.
BrownJ.V.BakemanR.ColesC.SexsonW.R.DemiA.S.1998Maternal drug use during pregnancy: Are preterm and full-term infants affected differently?Developmental Psychology34:540–554.
6.
ChasnoffI.GriffithD.MacGregorS.DirkesK.BurnsK.A.1989Temporal patterns of cocaine use in pregnancy: Perinatal outcome. JAMA261:1741–1744.
7.
ChiribogaC.BrustJ.BatemanD.HauserW.A.1999Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics103:79–85.
8.
ChurchM. W.HolmesP.OverbeckG.TilakJ.ZajacC.1991Interaction effects of prenatal alcohol and cocaine exposure on postnatal mortality, development, and behavior in the Long-Evans rat. Neurotoxicology and Teratology13:377–386.
9.
ColesC.D.PlatzmanK.A.SmithI.JamesM.E.FalekA.1992Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicology and Teratology14:23–33.
10.
Delaney-BlackV.CovingtonC.OstreaE.RomeroA.BakerD.TagleM.T.Nordstrom-KleeB.SilvestreM.A.AngelilliM.H.HackC.LongJ.1996Prenatal cocaine and neonatal outcome: Evaluation of dose-response relationship. Pediatrics98:735–740.
11.
EylerF.D.BehnkeM.ConlonM.WoodsN.S.WobieK.1998Birth outcomes from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics101:237–241.
12.
FieldT.1995Infants of depressed mothers. Infant Behavior and Development18:1–13.
13.
FormanR.SchneidermanJ.KleinJ.GrahamK.GreenwaldM.KorenG, 1992Accumulation of cocaine in maternal and fetal hair: The dose-response curve. Life Sciences50:1333–1341.
14.
FrancisD.FletcherJ.StuebingK.DavidsonK.ThompsonN.1991Analysis of change in modeling individual growth. Journal of Consulting and Clinical Psychology59:27–37.
15.
GawinF.H.1991Cocaine addition: Psychology and neurophysiology. Science251:1580–1586.
16.
GrantT.BrownZ.CallahanC.BarrH.StreissguthA.P.1994Cocaine exposure during pregnancy: Improving assessment with radioimmunoassay of maternal hair. Obstetrics and Gynecology83:524–531.
17.
GriffinM.L.WeissR.S.MirinS.M.LangeU.1989A comparison of male and female cocaine abusers. Archives of General Psychiatry46:122–126.
18.
HurtH.BrodskyN.L.BetancourtL.BraitmanL.E.MalmudE.GiannettaJ.1995Cocaine-exposed children: Follow-up through 30 months. Developmental and Behavioral Pediatrics16:29–35.
19.
JacobsonS. W.JacobsonJ.L.SokolR.J.MartierS.S.ChiodoL.M.1996New evidence of neurobehavioral effects of in utero cocaine exposure. The Journal of Pediatrics129:581–588.
20.
JacobsonJ.JacobsonS.1999Assessing neurotoxicity in children. In TilsonH.A.HarryG.J., eds., Nervous System Toxicology, third edition. Taylor and Francis: Bristol, PN.
21.
KandelD.WarnerL.KesslerR.1998The epidemiology of substance use and dependence among women. In WestheringtonC.RomanA., eds., Drug Addiction Research and the Health of Women, U.S. Department of Health and Human Services, National Institute on Drug Abuse: Rockville, MD.
22.
KesslerR.C.NelsonC.B.McGonagleK.A.EdlundM.J.FrankK.G.LeafP.J.1996The epidemiology of co-occurring mental disorders and substance use disorders in the National Co-Morbidity Survey. American Journal of Orthopsychiatry66:17–31.
23.
KleinmanP.H.MillerA.B.MillmanR.B.WoodyG.E.ToddT.KampJ.LiptonD.S.1990Psychopathology among cocaine abusers entering treatment. The Journal of Nervous and Mental Disease178:442–447.
24.
LewisD.MooreC.LeikinJ.1994Cocaethylene in meconium specimens. Clinical Toxicology32:697–703.
25.
MerikangasK.R.RischN.J.WeissmanM.M.1994Co-morbidity and co-transmission of alcoholism, anxiety, and depression. Psychological Medicine24:69–80.
26.
MinnesS.SingerL.FarkasK.1998Neuropsychological functioning, psychological distress, and maternal infant interaction in cocaine using women. Infant Behavior and Development21:579 (Abstract).
27.
MirochnickM.FrankD.A.CabralH.TurnerA.ZuckermanB.1995Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. Journal of Pediatrics126:636–638.
28.
OstreaE. M.BradyM.J.ParksP.M.AsensioD.C.NaluzA.1989Drug screening of meconium in infants of drug dependent mothers. Journal of Pediatrics115:474–477.
29.
PeindlK.S.WisnerK.L.HanosaB.H.1998Alcohol dependency and affective illness among women of child bearing. Archives of Women's Mental Health1:117–123.
30.
RichardsonG.A.HamelS.C.GoldschmidtL.DayN.L.1996The effects of prenatal cocaine use on neonatal neurobehavioral status. Neurotoxicology and Teratology18:519–528.
31.
SingerL.T.1997Methodological considerations in longitudinal studies of infant risk. In DobbingJ., ed., Developing Brain and Behaviour: The Role of Lipids in Infant Formula, Academic Press: New York, 209–251.
32.
SingerL.T.ArendtR.A.FaganJ.F.MinnesS.SalvatorA.BolekT.BeckerM.1999Neonatal visual information processing in cocaine-exposed and non-exposed infants. Infant Behavior and Development22:1–15.
33.
SingerL.ArendtR.FarkasK.MinnesS.HuangJ.YamashitaT.1997Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome. Development and Psychopathology9:473–489.
34.
SingerL. T.ArendtR.SongL.WarshawskyE.KliegmanR.1994Direct and indirect interactions of cocaine with childbirth outcomes. Archives of Pediatrics and Adolescent Medicine148:959–964.
35.
SingerL.T.FarkasK.ArendtR.MinnesS.YamashitaT.KliegmanR.1995Postpartum psychological distress in cocaine using mothers. Journal of Substance Abuse7:165–174.
36.
SingerL.T.ArendtR.MinnesS.FarkasJ.CollinM.YamashitaT.1997Fetal cocaine exposure and birth outcomes: Biologic and self-report measures. Abstracts of the Fifty Ninth Annual Scientific Meeting, College on Problems of Drug Dependence 59:153.
37.
SternM.HilderbrandtK.A.1986Prematurity stereotyping: Effects on mother-child interaction. Child Development57:308–315.
38.
Strano-RossiS.1999Methods used to detect drug abuse in pregnancy: A brief review. Drug and Alcohol Dependence53:257–71.
39.
TronickE.Z.FrankD.CabralH.MirochnickM.ZuckermanB.1996Late dose response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics98:76–83.
40.
U.S. Department of Health and Human Services1993Pregnancy and exposure to drugs. Public Health Service, Substance Abuse and Mental Health Administration, Center for Substance Abuse Prevention Technical Report.
41.
U.S. Department of Health and Human Services1996Drug use among racial/ethnic minorities. National Institutes of Health, Division of Epidemiology and Prevention Research, National Institute on Drug Abuse.
42.
WeissR.D.GriffinM.L.MurinS.M.1989Diagnosing major depression in cocaine abusers. Psychiatry Research28:335–343.
43.
WhiffenV.E.GottliebI.M.1989Infants of postpartum depressed mothers: Temperament and cognitive status. Journal of Abnormal Psychology98:274–279.
44.
WilcoxR.1998How many discoveries have been lost by ignoring modern statistical methods?American Psychologist53:300–314.
45.
WoodT.PlessingerM.ClarkK.1987Effects of cocaine on uterine blood flow and fetal oxygenation. Journal of the American Medical Association257:957–961.
46.
WoodsN.S.EylerF.BehnkeM.ConlonM.1993Cocaine use during pregnancy: Maternal depressive symptoms and infant neurobehavior during the first month of life. Infant Behavior and Development16:83–98.
47.
ZuckermanB.AlsH.BauchnerH.ParkerS.CabralH.1990Maternal depressive symptoms during pregnancy, and newborn irritability. Developmental and Behavioral Pediatrics11:190–194.
48.
ZuckermanB.FrankD.A.HingsonR.AmaroH.LevensonS.KayneH.ParkerS.VinciR.AboagyeK.FriedL.CabralH.TompieriR.BauchnerS.1989Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine320:762–768.